Arlington Partners’s HCA Healthcare HCA Stock Holding History

Arlington Partners’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-28	Closed	-$7.58K	–	138
2023 Q4	$7.58K	Sell	28 -9	-24%	-$2.22K	﹤0.01%	232
2023 Q3	$9.1K	Sell	37 -3,008	-99%	-$823K	﹤0.01%	241
2023 Q2	$924K	Hold	3,045	–	–	0.14%	66
2023 Q1	$803K	Buy	3,045 +909	+43%	+$231K	0.11%	62
2022 Q4	$513K	Sell	2,136 -250	-10%	-$56K	0.08%	64
2022 Q3	$439K	Hold	2,386	–	–	0.18%	63
2022 Q2	$401K	Hold	2,386	–	–	0.13%	77
2022 Q1	$598K	Sell	2,386 -13	-0.5%	-$3.27K	0.17%	60
2021 Q4	$616K	Buy	2,399 +41	+2%	+$10K	0.17%	60
2021 Q3	$572K	Hold	2,358	–	–	0.16%	63
2021 Q2	$487K	Sell	2,358 -61	-3%	-$12.4K	0.17%	56
2021 Q1	$456K	Buy	2,419 +409	+20%	+$72.1K	0.17%	57
2020 Q4	$331K	Hold	2,010	–	–	0.15%	56
2020 Q3	$251K	Hold	2,010	–	–	0.14%	59
2020 Q2	$195K	Hold	2,010	–	–	0.11%	66
2020 Q1	$181K	Hold	2,010	–	–	0.09%	77
2019 Q4	$297K	Hold	2,010	–	–	0.18%	45
2019 Q3	$242K	Hold	2,010	–	–	0.15%	49
2019 Q2	$272K	Sell	2,010 -100	-5%	-$12.6K	0.12%	76
2019 Q1	$275K	Buy	+2,110	New	+$283K	0.2%	45

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arlington Partners's HCA Position: Q1 2024 in Review

Arlington Partners sold out of HCA Healthcare (HCA) in Q1 2024, closing a stake of 28 shares — an estimated $7.58K sold.

Arlington Partners first reported a position in HCA in Q1 2019 and held it in 20 quarters. The position peaked at $924K in Q2 2023. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.

Arlington Partners reported no remaining HCA Healthcare position as of Q1 2024 after selling out during the quarter.
Arlington Partners sold 28 HCA Healthcare shares in Q1 2024, an estimated $7.58K.
Arlington Partners first reported a position in HCA Healthcare in Q1 2019 and held it in 20 quarters.
Arlington Partners's HCA Healthcare position peaked at $924K in Q2 2023.
1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.

Based on Arlington Partners's 13F filing for Q1 2024, filed 16 Apr 2024.